Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited)

v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenue, net $ 8,433,000 $ 8,849,000 $ 16,003,000 $ 17,638,000
Cost of revenue 4,791,000 4,556,000 8,952,000 9,216,000
Gross profit 3,642,000 4,293,000 7,051,000 8,422,000
Operating expenses        
Selling, general and administrative 6,766,000 3,181,000 12,911,000 6,214,000
Research and development 2,355,000 1,116,000 4,420,000 2,426,000
Total operating expenses 9,121,000 4,297,000 17,331,000 8,640,000
Loss from operations (5,479,000) (4,000) (10,280,000) (218,000)
Other income (expense)        
Long-term debt forgiveness 0 0 0 2,000,000
Change in fair value of warrant liabilities 765,000 0 1,527,000 0
Interest expense 0 (130,000) 0 (281,000)
Interest income 1,000 0 2,000 0
Other income 38,000 1,000 39,000 1,000
Total other income (expense), net 804,000 (129,000) 1,568,000 1,720,000
(Loss) income before income tax benefit (4,675,000) (133,000) (8,712,000) 1,502,000
Income tax benefit (expense) 1,000 (2,000) 1,000 71,000
Net (loss) income $ (4,674,000) $ (135,000) $ (8,711,000) $ 1,573,000
Net (loss) income per share:        
Basic (in USD per shares) $ (0.09) $ 0 $ (0.16) $ 0.04
Diluted (in USD per shares) $ (0.09) $ 0 $ (0.16) $ 0.04
Weighted average common shares outstanding:        
Basic (in shares) [1] 53,069,269 36,079,478 52,925,199 36,043,718
Diluted (in shares) [1] 53,069,269 36,079,478 52,925,199 36,043,718
Other comprehensive (loss) income        
Foreign currency translation adjustment $ (174,000) $ (8,000) $ (226,000) $ (17,000)
Comprehensive (loss) income $ (4,848,000) $ (143,000) $ (8,937,000) $ 1,556,000
[1] Retroactively restated the common shares for 2021 due to the reverse recapitalization as described in Notes 1 and 11.